IBA BUSINESS UPDATE – FIRST QUARTER 2019

    NEXT STORY
    Roche to present new OCREVUS (ocrelizumab) data analyses showing significant reduction of disability progression in relapsing and primary progressive multiple sclerosis at the AAN Annual Meeting
    PREV STORY
    OPKO Health Reports 2019 First Quarter Business Highlights and Financial Results
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Sun BioPharma, Inc. Announces Appointment of Susan Horvath as Vice President of Finance and Chief Financial Officer

    author_avatar
    NASDAQ Market News

    Esperite Group with The Cell Factory, expands its patent portfolio on extra-cellular vesicles biologic drugs in Canada.

    Amsterdam, the Netherlands - 7 November 2018 Esperite's (Euronext: ESP) biotech company The Cell Factory ...

    author_avatar
    NASDAQ Market News

    GeoVax Announces 100% Protection Data from Marburg Virus Vaccine Study

    author_avatar
    NASDAQ Market News